Platelet Indices and Recurrent Pregnancy Loss (NCT05190796) | Clinical Trial Compass
CompletedNot Applicable
Platelet Indices and Recurrent Pregnancy Loss
Egypt150 participantsStarted 2020-09-01
Plain-language summary
The aim of this study was to evaluate relationship between platelet indices, red blood cell indices and recurrent pregnancy loss.
Who can participate
Age range18 Years – 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* patients with Recurrent miscarriage is defined as three or more consecutive pregnancy losses at or less than 20 weeks of gestation or with a fetal weight less than 500 grams
Exclusion Criteria:
* A woman who had experienced recurrent pregnancy loss due to uterine anomalies, diabetes mellitus and thyroid disease.
* Hypertensive women.
* Patients with coagulation defects.
* History of deep vein thrombosis or pulmonary thromboembolism.
* Use of medications affecting platelet functions such as aspirin, nonsteroidal anti-inflammatory drugs, oral contraceptives, hormonal treatments, anti-platelet, and anticoagulant drugs.